The New Jersey decision ignores the fact that Johnson & Johnson has admitted in internal documents that its talc powder product carries a cancer risk. Read more
The class action complaint, which was filed in May 2014, alleges that Johnson & Johnson concealed from consumers the serious risks of ovarian cancer. Read more
Johnson & Johnson worked in concert with its talc supplier, Imerys Talc America, Inc., and the cosmetic trade organization, the Personal Care Products Council. Read more
The suit is making several claims against Johnson & Johnson and Janssen. Read more
The suit was filed against McNeil in 2011 after the child died of sepsis caused by pneumonia several days after ingesting Children's Tylenol. Read more
Risperdal went on the market in 1993 after receiving approval from the FDA for the treatment of schizophrenia. Read more
The jury found in favor of J&J on all counts. Read more
Johnson & Johnson bought the company for $785 million in 2010, earning Facteau $32 million and Fabian $4 million. Read more
Beasley, Allen, Crow, Methvin, Portis & Miles has been selected as a finalist for the 2016 Public Justice Trial Lawyer of the Year award for the firm’s work on litigation related to John... Read more
Mrs. Ristesund was diagnosed with ovarian cancer in 2011 after using Johnson’s Baby Powder for feminine hygiene for more than 40 years. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.